Lv11
40 积分 2021-07-07 加入
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
1小时前
待确认
Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel
12天前
已完结
Beyond the blood: expanding CAR T cell therapy to solid tumors
1个月前
已完结
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study
2个月前
已完结
Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile
2个月前
已完结
肺癌免疫治疗的研究进展
2个月前
已完结
第5版WHO儿童肿瘤分册简介
2个月前
已完结
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study
2个月前
已完结
复发/难治急性B淋巴细胞白血病行CAR-T细胞治疗后接受粒细胞集落刺激因子的疗效及安全性分析
2个月前
已完结
Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
3个月前
已完结
皖公网安备34019202002308
